Biotech Scientific Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 01-01-2025
- Paid Up Capital ₹ 1.50 M
as on 01-01-2025
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
as on 01-01-2025
- Revenue -0.96%
(FY 2020)
- Profit 1.95%
(FY 2020)
- Ebitda 77.54%
(FY 2020)
- Net Worth -58.06%
(FY 2020)
- Total Assets -19.22%
(FY 2020)
About Biotech Scientific
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.00 M.
Prajitha Udayakumar and Thazhe Kumar serve as directors at the Company.
- CIN/LLPIN
U52310KL2014PTC036965
- Company No.
036965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Biotech Scientific Private Limited offer?
Biotech Scientific Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Biochemistry Analyzer, Chemistry Analyzers, IVDs & Analyzers, Laboratory Glassware, Laboratory Ware.
Who are the key members and board of directors at Biotech Scientific?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thazhe Kumar  | Managing Director | 24-Jul-2014 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prajitha Udayakumar | Director | 24-Jul-2014 | Current |
Financial Performance of Biotech Scientific.
Biotech Scientific Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 0.96% decrease. The company also saw a slight improvement in profitability, with a 1.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 58.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotech Scientific?
In 2016, Biotech Scientific had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oxalt Asia Medico Private LimitedActive 6 months 6 daysPrajitha Udayakumar and Thazhe Kumar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Union Bank Of India Creation Date: 05 Sep 2014 | ₹1.00 M | Open |
How Many Employees Work at Biotech Scientific?
Unlock and access historical data on people associated with Biotech Scientific, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotech Scientific, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotech Scientific's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
